RiceBran Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

RiceBran Technologies has a total shareholder equity of $-4.7M and total debt of $3.9M, which brings its debt-to-equity ratio to -81.7%. Its total assets and total liabilities are $5.1M and $9.8M respectively.

Belangrijke informatie

-81.7%

Verhouding schuld/eigen vermogen

US$3.87m

Schuld

Rente dekkingsratio	n/a
Contant	US$448.00k
Aandelen	-US$4.73m
Totaal verplichtingen	US$9.79m
Totaal activa	US$5.05m

Recente financiële gezondheidsupdates

Recent updates

Investors Aren't Entirely Convinced By RiceBran Technologies' (NASDAQ:RIBT) Revenues

Apr 17

Analyse van de financiële positie

Kortlopende schulden: RIBT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langlopende schulden: RIBT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: RIBT has negative shareholder equity, which is a more serious situation than a high debt level.

Schuld verminderen: RIBT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: RIBT has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.

Voorspelling contante baan: RIBT is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.

RiceBran Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

RiceBran Technologies announced delayed 10-Q filing

Ricebran Technologies Receives Staff Delisting Determination from Nasdaq Due to Non-Compliance with the Minimum $2,500,000 Stockholders’ Equity Requirement for Continued Listing as Set Forth in Nasdaq Listing Rule 5550(b)

Ricebran Technologies Receives Non-Compliance Notice from Nasdaq

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies Receives Notice from the Staff of the Nasdaq Regarding Non-Compliance with Nasdaq Minimum Bid Price Requirement

RiceBran Technologies Regains Compliance with Nasdaq Bid Price Rule

Recent updates

RiceBran Technologies Announces Board Appointments

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies(OTCPK:RIBT) dropped from S&P TMI Index

Ricebran Technologies Receives Staff Delisting Determination from Nasdaq Due to Non-Compliance with the Minimum $2,500,000 Stockholders’ Equity Requirement for Continued Listing as Set Forth in Nasdaq Listing Rule 5550(b)

Ricebran Technologies Receives Non-Compliance Notice from Nasdaq

RiceBran Technologies, Annual General Meeting, Oct 16, 2023

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies, Annual General Meeting, Oct 10, 2023

Stabil Nutrition, LLC acquired Stabilized Rice Bran Business from RiceBran Technologies (NasdaqCM:RIBT) for $1.8 million.

RiceBran Technologies Receives Notice from the Staff of the Nasdaq Regarding Non-Compliance with Nasdaq Minimum Bid Price Requirement

Ricebran Technologies Announces Board Changes

First quarter 2023 earnings released: US$0.31 loss per share (vs US$0.29 loss in 1Q 2022)

Investors Aren't Entirely Convinced By RiceBran Technologies' (NASDAQ:RIBT) Revenues

Full year 2022 earnings released: US$1.43 loss per share (vs US$1.88 loss in FY 2021)

Third quarter 2022 earnings released: US$0.38 loss per share (vs US$0.47 loss in 3Q 2021)

RiceBran Technologies has completed a Follow-on Equity Offering in the amount of $1.499968 million.

RiceBran Technologies has completed a Follow-on Equity Offering in the amount of $1.5 million.

RiceBran technologies shares slip on $1.5M registered direct offering

RiceBran Technologies Regains Compliance with Nasdaq Bid Price Rule

RiceBran regains compliance with Nasdaq bid price rule

Here's Why RiceBran Technologies (NASDAQ:RIBT) Can Afford Some Debt

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

RiceBran Technologies, Annual General Meeting, Jul 14, 2022

Does RiceBran Technologies (NASDAQ:RIBT) Have A Healthy Balance Sheet?

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Less than half of directors are independent

Price target decreased to US$0.65

Is RiceBran Technologies (NASDAQ:RIBT) Using Too Much Debt?

Third quarter 2021 earnings released: US$0.047 loss per share (vs US$0.068 loss in 3Q 2020)

We Think RiceBran Technologies (NASDAQ:RIBT) Has A Fair Chunk Of Debt

Consensus EPS estimates fall to -US$0.09

Second quarter 2021 earnings released: US$0.042 loss per share (vs US$0.099 loss in 2Q 2020)

Does RiceBran Technologies (NASDAQ:RIBT) Have A Healthy Balance Sheet?

First quarter 2021 earnings released: EPS US$0.013 (vs US$0.076 loss in 1Q 2020)

RiceBran Technologies EPS beats by $0.05, beats on revenue

Full year 2020 earnings released: US$0.28 loss per share (vs US$0.42 loss in FY 2019)

Revenue and earnings miss expectations

Ricebran Technologies Regains Compliance with Nasdaq Bid Price Rule

Would RiceBran Technologies (NASDAQ:RIBT) Be Better Off With Less Debt?

New 90-day high: US$1.32

New 90-day high: US$0.93

New 90-day high: US$0.84

New 90-day high: US$0.72

Revenue behind estimates

Third quarter 2020 earnings released: US$0.068 loss per share

New 90-day low: US$0.41

New 90-day low - US$0.54

Analysts lower revenue estimates to US$27.8m

Earnings released

Ricebran Announces the Step Down of Brent Rystrom as CEO

New 90-day low - US$0.74

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven